Celares GmbH is a Contract Development and Manufacturing Organisation (CDMO) that specializes in the development and manufacturing of polymer-based drug delivery excipients and bioconjugate drugs. With a focus on customised conjugation solutions, Celares has established expertise in the development of PEGylated biomolecules and multiple antibody-related services, demonstrating a commitment to advancing pharmaceutical and biopharmaceutical innovations.

Services include:
- Accelerated Stability Studies
- Analytical Services
- Bioanalytical Services
- Biologics
- Process Development
- Biosimilars
- Contract Development and Manufacturing (CDMO)
- Contract Manufacturing (CMO)
- Contract Research (CRO)
- Custom Synthesis
- Feasibility Studies
- Process Validation Studies
- Stability Studies
- APIs (Active Pharmaceutical Ingredients)

Celares is dedicated to supporting the pharmaceutical industry with high-quality solutions tailored to meet client needs. For more information, please visit celares.com.